The uniform selling direction across the entire C-suite without any offsetting purchases is unusual for a routine liquidity event. Monitor for any upcoming earnings pre-announcement, regulatory update on the iLet bionic pancreas, or material change in commercial traction that may have prompted coordinated selling.
Price Chart
Executive Summary
Five Beta Bionics insiders, including the CEO, CFO, and Chief Commercial Officer, sold a total of $1.09M in open-market sales over a one-week window. The selling is broad-based across the C-suite and represents approximately 0.33% of the company's $326M market cap, a modest but notable cluster. No insider purchases offset the selling, and the pattern is not clearly 10b5-1 driven given the concentrated window and varying prices.
Key Financial Metrics
Key Facts
- Five insiders sold shares in open-market transactions totaling $1.09M from Sept 2-9, 2026.
- CEO Sean Saint sold $113K, CFO Stephen Feider sold $128K, and CCO Mark Hopman sold $681K.
- No insider purchases were reported in the cluster window.
- Total sales represent ~0.33% of BBNX's $326M market cap.
- The cluster is broad-based across C-suite and CMO, not limited to one executive.
Financial Impact
Insider sales of $1.09M, or ~0.33% of market cap, in a concentrated window with no buys.
Risk Factors
- Insider selling may signal management's view that the stock is fairly valued or that near-term headwinds exist.
- The company is pre-profitability; sustained insider selling could erode investor confidence ahead of key catalysts.
- No 10b5-1 plan disclosures were noted, raising the possibility of discretionary sales.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BBNX-1789775575998 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $20.50 | awaiting T+20 | — | $21.39 (+4.34%) |
Oct 27, 2026 today | Press Release | $20.27 | awaiting T+20 | — | $21.39 (+5.53%) |
Oct 7, 2026 20d ago | SC 13G | $18.08 | awaiting T+20 | — | $21.39 (+18.31%) |
Sep 23, 2026 4w ago | Insider Cluster | $21.76 $19.34 | ▲ +11.12% | ▲ +10.70% | $21.39 (+1.70%) |
Sep 18, 2026 5w ago | Insider Cluster | $22.04 $16.84 | ▲ +23.59% | ▲ +22.69% | $21.39 (+2.95%) |
Sep 17, 2026 5w ago | Press Release | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $21.39 (−2.28%) |
Sep 17, 2026 5w ago | Insider Cluster | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $21.39 (−2.28%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $21.39 (+3.56%) |
Sep 15, 2026 6w ago | 8-K | $22.18 $16.87 | ▼ −23.94% | ▼ −26.00% | $21.39 (−3.56%) |
Sep 15, 2026 6w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $21.39 (+3.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers